Possible PBS listing for dabrafenib and trametinib

Possible PBS listing for dabrafenib and trametinib

18 December 2018

Dabrafenib and trametinib are being considered by the Pharmaceutical Benefits Advisory Committee (PBAC) for the adjuvant treatment of resected Stage III melanoma in BRAF positive patients.

Listing on the PBS would provide these treatments at a subsidised price to patients at an earlier stage of disease than currently available.

The Therapeutic Goods Administration (TGA) approved this combination therapy in June 2018 for resected Stage III patients. The combination of dabrafenib and trametinib is listed on the Pharmaceutical Benefits Scheme (PBS) for unresectable Stage III and Stage IV melanoma only.

Should you wish to provide comment to the PBAC, the Consumer Comments portal on the PBS website can be found here. The portal will close on 13 February 2019, prior to the PBAC Meeting in March.

First patient recruited to the EAGLE FM Trial
09 Mar 2015

First patient recruited to the EAGLE FM Trial

Evaluation of Groin Lymphadenectomy Extent for Metastatic Melanoma (EAGLE FM) clinical trial has recruited its first patient.  

Online Comments to the Pharmaceutical Benefits Advisory Committee
09 Feb 2015

Online Comments to the Pharmaceutical Benefits Advisory Committee

You are invited to provide comments for consideration by the Pharmaceutical Benefits Advisory Committee (PBAC). The PBAC will consider the registration of the anti-PD1 drug, Keytruda (pembrolizumab) at the next meeting in March.

A man of commitment
06 Feb 2015

A man of commitment

Melanoma patient Joel Allsop was congratulated today on completing his participation in the international surgical clinical trial, known as MSLT-II. He was the first person in the world to complete the 10 years of follow-up for this trial. 

Melanoma March has officially launched
05 Feb 2015

Melanoma March has officially launched

Melanoma Institute Australia (MIA) has officially launched the 2015 ‘Melanoma March’ initiative in Melbourne. 

Melanoma March is around the corner
02 Feb 2015

Melanoma March is around the corner

Help us march towards a cure for melanoma research. See where your local march is and how you can get involved.

Q&A with a PhD student
28 Jan 2015

Q&A with a PhD student

Under the leadership of world-leading melanoma pathologist Prof Richard Scolyer and medical oncologist A/Prof Georgina Long, third year PhD student, Hojabr Kakavand, is at the forefront of melanoma research. 

ClinTrial Refer Melanoma App
22 Jan 2015

ClinTrial Refer Melanoma App

Melanoma Institute Australia has launched a new smartphone app called ClinTrial Refer Melanoma to help busy clinicians find clinical trials for their melanoma patients.

Interview on the latest melanoma treatments
08 Jan 2015

Interview on the latest melanoma treatments

MIA's Associate Professor Georgina Long and stage 4 melanoma patient, Maria, were recently interviewed by ABC Weekend Breakfast about the latest in clincial trials and melanoma treatments.

Sunbed campaigner acknowledged as one of most influential Australians
17 Dec 2014

Sunbed campaigner acknowledged as one of most influential Australians

Sunbed campaigner, Jay Allen, has been acknowledged on the honour roll of Australia’s most influential people in the non-profit sector.

A world-class organisation needs a world-class website
03 Dec 2014

A world-class organisation needs a world-class website

Today we launch the website we’ve dreamed about!

Watch Your Mate's Back kicks off
01 Dec 2014

Watch Your Mate's Back kicks off soon

Our new summer campaign has you and your mates' backs covered!

Saving our next generation
18 Nov 2014

Saving our next generation

Researcher James Wilmott is working to fill a gap in research for young patients.

It's time to march for a cure!
17 Nov 2014

It's time to march for a cure!

Join us for our fourth annual Melanoma March and help us raise over $1 million for melanoma research as we march for a cure! 

Making a difference
17 Nov 2014

Making a difference

When Melanoma Institute Australia (MIA) patients at the Poche Centre are first diagnosed with advanced melanoma Anna Hoadley is there.

New trial offers hope to Stage IV patients
17 Nov 2014

New trial offers hope to Stage IV patients

Shining new hope for patients with advanced stage melanoma.

Combination drug therapy halts disease in advanced melanoma
29 Sep 2014

Combination drug therapy halts disease in advanced melanoma

A world-first study in the New England Journal of Medicine heralds the effectiveness of a targeted combination drug therapy after reporting major declines in the risk of disease progression and death in people with metastatic melanoma.

Georgina Long wins award for Outstanding Cancer Research
22 Aug 2014

Georgina Long wins award for Outstanding Cancer Research

Associate Professor Georgina Long wins award for Cancer Institute NSW

Melanoma survivors walk from Sydney to Melbourne to raise money
26 Jul 2014

Melanoma survivors walk from Sydney to Melbourne to raise money

Melanoma survivors and long-time friends Jay Allen and Andrew Rust concluded their 900km walk from Sydney to Melbourne completing their walk at the Melbourne Cricket Ground on Saturday 26 July.

The Federal Government's 2015-16 Budget announcements benefit research

The Federal Government's 2015-16 Budget announcements benefit research

The Federal Government’s 2015-16 Budget was announced this week with a boost for medical research funding.